Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma

The pathogenesis of follicular lymphoma is a multi-step process, in which chromosomal translocation between immunoglobulin heavy chain (IgH) and anti-apoptotic B-cell lymphoma 2 (BCL2), namely IgH-BCL2, is an earliest step, followed by other genetic/genomic alterations including but not limited to m...

Full description

Bibliographic Details
Published in:	Frontiers in Oncology
Main Authors:	Huan-You Wang, Ethan S. Sokol, Aaron M. Goodman, Andrew L. Feldman, Carolyn M. Mulroney
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Subjects:	CIITA CIITA-CREBBP follicular lymphoma BCL 2 CREBBP TBL1XR1-TP63
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.620435/full

Similar Items

The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy
by: Greta Forlani, et al.
Published: (2023-10-01)

Fusions involving BCOR and CREBBP are rare events in infiltrating glioma
by: David J. Pisapia, et al.
Published: (2020-06-01)

CNS tumor with CREBBP::BCORL1 Fusion and pathogenic mutations in BCOR and CREBBP: expanding the spectrum of BCOR-altered tumors
by: Valeria Barresi, et al.
Published: (2024-01-01)

Differential expression of the inflammatory ciita gene may be accompanied by altered bone properties in intact sex steroid-deficient female rats
by: Vivi FH Jensen, et al.
Published: (2023-12-01)

Mutation in the CREBBP Gene in the Girl with Toe Walking Syndrome: Clinical Case
by: David Pomarino, et al.
Published: (2021-10-01)

Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA
by: Fabrizio Celesti, et al.
Published: (2023-03-01)

Production of Triple-Gene (GGTA1, B2M and CIITA)-Modified Donor Pigs for Xenotransplantation
by: Kaixiang Xu, et al.
Published: (2022-04-01)

Borrelia burgdorferi sensu lato inhibits CIITA transcription through pSTAT3 activation and enhanced SOCS1 and SOCS3 expression leading to limited IFN-γ production
by: Michelle A.E. Brouwer, et al.
Published: (2025-01-01)

PM<sub>2.5</sub> Extracts Induce INFγ-Independent Activation of CIITA, MHCII, and Increases Inflammation in Human Bronchial Epithelium
by: Héctor Jirau-Colón, et al.
Published: (2024-04-01)

A case with Rubinstein-Taybi syndrome: A novel frameshift mutation in the CREBBP gene
by: Metin Eser, et al.
Published: (2017-10-01)

CREBBP is a Major Prognostic Biomarker for Relapse in Childhood B-cell Acute Lymphoblastic Leukemia: A National Study of Unselected Cohort
by: Krstevska Bozhinovikj E, et al.
Published: (2025-03-01)

Multiple sclerosis susceptibility in a Brazilian sample, HLA and CIITA genes
by: Eduardo Ribeiro Paradela
Published: (2014-06-01)

New insights into genetic variant spectrum and genotype–phenotype correlations of Rubinstein‐Taybi syndrome in 39 CREBBP‐positive patients
by: Virginia Pérez‐Grijalba, et al.
Published: (2019-11-01)

Clinical exome sequencing identifies novel CREBBP variants in 18 Chinese Rubinstein–Taybi Syndrome kids with high frequency of polydactyly
by: Sha Yu, et al.
Published: (2019-12-01)

The CIITA genetic polymorphism rs4774*C in combination with the HLA-DRB1*15:01 allele as a putative susceptibility factor to multiple sclerosis in Brazilian females
by: Eduardo R. Paradela, et al.
Published: (2015-04-01)

Rubinstein-Taybi syndrome with ganglioneuroblastoma: a case report and literature review
by: Jiaji Zhou, et al.
Published: (2025-03-01)

Functional disruption of human leukocyte antigen II in human embryonic stem cell
by: Haide Chen, et al.
Published: (2015-01-01)

Adolescent cetylpyridinium chloride exposure impairs homologous recombination repair and induces granulosa cell apoptosis and follicular atresia via FOXM1/CREBBP complex suppression
by: LiYao Ma, et al.
Published: (2025-05-01)

A significant correlation exists between CREBBP and CEBPA gene expression in de Novo adult acute myeloid leukemia
by: Magda Assem, et al.
Published: (2025-04-01)

Urinary Sediment mRNA Level of CREBBP and CYBA in Children With Steroid-Resistant Nephrotic Syndrome
by: Wei Li, et al.
Published: (2022-01-01)

Class II Transactivator Gene (CIITA) Variants Associated with Bare Lymphocyte Syndrome II in a Female Sudanese Patient
by: Salih OAMM, et al.
Published: (2024-09-01)

Identification of a novel, pathogenic CREBBP variant in a patient with Menke-Hennekam syndrome: a Case Report
by: Anna Μaria Anastasiou, et al.
Published: (2025-08-01)

Class II transactivator restricts viral replication, extending its effect to HBV: Editorial on “Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction”
by: Cho-Rong Lee, et al.
Published: (2024-10-01)

Reply to correspondence on “Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction”
by: Cho-Rong Lee, et al.
Published: (2024-10-01)

Molecular-genetic basis of Rubinstein–Taybi syndrome
by: O. R. Ismagilova, et al.
Published: (2023-06-01)

Case report: A late and isolated presentation of meningoencephalomyelitis uncovers a novel pathogenic variant in the CIITA gene
by: Mohammed F. Alosaimi, et al.
Published: (2023-09-01)

Next generation sequencing identified two novel mutations in NIPBL and a frame shift mutation in CREBBP in three Chinese children
by: Hui Tang, et al.
Published: (2019-02-01)

BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion
by: Azadeh Ebrahimi, et al.
Published: (2024-04-01)

Характеристика цитогенетических и молекулярно-генетических нарушений гена CIITA у пациентов с первичной медиастинальной (тимической) В-крупноклеточной лимфомой
by: Светлана Александровна Кузнецова, et al.
Published: (2021-04-01)

Class II transactivator induces expression of MHC-I and MHC-II in transmissible Tasmanian devil facial tumours
by: Chrissie E. B. Ong, et al.
Published: (2022-10-01)

Small cell pattern of ALK‐negative anaplastic large cell lymphoma with double‐hit rearrangements of DUSP22 and TP63
by: Yui Niiyama‐Uchibori, et al.
Published: (2024-08-01)

Genomic Aberrations Generate Fusion Gene FOXK2::TP63 and Activate NFKB1 in Cutaneous T-Cell Lymphoma
by: Stefan Nagel, et al.
Published: (2022-08-01)

Diagnosis of Menke‐Hennekam syndrome by prenatal whole exome sequencing and review of prenatal signs
by: Guillaume Cogan, et al.
Published: (2023-09-01)

Exploration of the Pharmacological Mechanism of Vitexicarpin against Triple-Negative Breast Cancer in Network Pharmacology
by: Tianhui Wu, et al.
Published: (2023-12-01)

Novel vaccination strategies based on optimal stimulation of CD4+ T helper cells for the treatment of oral squamous cell carcinoma
by: Lorenzo Azzi, et al.
Published: (2024-07-01)

Potential small-molecule compounds and targets for Alzheimer's disease: Integrating bioinformatics analysis and in vitro verification
by: Jiaorong Zheng, et al.
Published: (2025-09-01)

A Ménage à trois: NLRC5, immunity, and metabolism
by: Fabienne Brunschwiler, et al.
Published: (2024-07-01)

A case of bilateral elbow dislocation in a patient with Rubinstein-Taybi syndrome
by: Yusuke Kawano, MD, PhD, et al.
Published: (2023-07-01)

Two decades of a protooncogene TBL1XR1: from a transcription modulator to cancer therapeutic target
by: Ruijuan Du, et al.
Published: (2024-01-01)

Different mutations in TBL1XR1 lead to diverse phenotypes of neurodevelopmental disorder: two case reports
by: Linlin Wei, et al.
Published: (2025-05-01)